sellWeak10b5-1 plan
BENKOWITZ MICHAEL sold $3.6M of UTHR
PRESIDENT AND COO at UNITED THERAPEUTICS Corp. 10,000 shares at an average of $356.68, traded Dec 30, 2024, filed Dec 31, 2024.
Warning score
30Value
$3.6M
10,000 shares
Holdings after
0
-133% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001562180-24-008661, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 30, 2024 | MOption exercise Common Stockindirect: By Trust10b5-1 | +7,500 | $111.00 | $833k | 7,500 | Dec 31, 2024 |
| Dec 30, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,318 | $355.46 | $468k | 6,182 | Dec 31, 2024 |
| Dec 30, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -3,025 | $356.38 | $1.1M | 3,157 | Dec 31, 2024 |
| Dec 30, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -2,757 | $357.28 | $985k | 400 | Dec 31, 2024 |
| Dec 30, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -400 | $358.18 | $143k | 0 | Dec 31, 2024 |
| Dec 30, 2024 | MOption exercise Common Stockindirect: By Trust10b5-1 | +2,500 | $111.00 | $278k | 2,500 | Dec 31, 2024 |
| Dec 30, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -500 | $355.69 | $178k | 2,000 | Dec 31, 2024 |
| Dec 30, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -820 | $356.51 | $292k | 1,180 | Dec 31, 2024 |
| Dec 30, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,080 | $357.37 | $386k | 100 | Dec 31, 2024 |
| Dec 30, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -100 | $358.17 | $36k | 0 | Dec 31, 2024 |
| Dec 30, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -2,500 | $0.00 | $0 | 24,500 | Dec 31, 2024 |
| Dec 30, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -7,500 | $0.00 | $0 | 67,179 | Dec 31, 2024 |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 45Moderate | sell 310b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 45Moderate | sell 410b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $6.1M | 15,000 | |
| 45Moderate | sell 410b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $10.0M | 25,000 | |
| 50Moderate | sell 4 | UTHR UNITED THERAPEUTICS Corp | Giltner Richard director | $3.8M | 10,000 | |
| 47Moderate | sell 410b5-1 | UTHR UNITED THERAPEUTICS Corp | EDGEMOND JAMES CFO AND TREASURER | $2.9M | 7,778 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.